Clinical Trials Logo

Metabolic Surgery clinical trials

View clinical trials related to Metabolic Surgery.

Filter by:
  • None
  • Page 1

NCT ID: NCT06275061 Recruiting - Obesity Clinical Trials

Chinese Obesity and MEtabolic Surgery Database (COMES Database)

COMES
Start date: May 1, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of the Chinese Obesity and MEtabolic Surgery Database (COMES Database) is to collect data and examine the long-term effects of metabolic and bariatric surgery on obesity and metabolic disorders in the Chinese population.

NCT ID: NCT04609449 Completed - Bariatric Surgery Clinical Trials

A Comparison Between Short vs. Long Biliopancreatic Limb Gastric Bypass

Start date: January 2016
Phase: N/A
Study type: Interventional

Prospective study including patients submitted to RYGB (n=94) and L-RYGB (n=94) at a single institution. The aim was to compare the effect on comorbidities and weight loss of a long biliopancreatic limb Roux-en-Y gastric bypass (L-RYGB), compared with a standard RYGB. Procedure selection was randomly assigned (1:1), and surgeries were performed, during 24 months (2016-2017). Weight loss, comorbidities control and nutritional status were assessed at baseline and 12 months.

NCT ID: NCT03891056 Recruiting - Diabetes Mellitus Clinical Trials

Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT)

MSO1CT
Start date: January 15, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to compare the efficacy of laparoscopic gastric bypass versus vertical gastrectomy for the resolution of DM in patients with BMI 30-35.

NCT ID: NCT03800160 Enrolling by invitation - Metabolic Surgery Clinical Trials

Greater China Metabolic and Bariatric Surgery Database

Start date: April 1, 2018
Phase:
Study type: Observational [Patient Registry]

Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.

NCT ID: NCT03520699 Recruiting - Metabolic Surgery Clinical Trials

Beijing Friendship Hospital Metabolic Surgery Database

Start date: December 1, 2017
Phase:
Study type: Observational [Patient Registry]

Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.

NCT ID: NCT03467581 Recruiting - Metabolic Surgery Clinical Trials

Five-year Outcome of Laparoscopic Gastric Sleeve

Start date: October 8, 2008
Phase: N/A
Study type: Observational

The aim of this study is to evaluate the long-term (5-year follow-up) results of laparoscopic gastric sleeve (LGS) in terms of weight loss and obesity related comorbidities, as well as the risk factors associated with postoperative nutritional deficiencies.

NCT ID: NCT03412253 Suspended - Metabolic Surgery Clinical Trials

Could Single-anastomosis Gastric Bypass Be a Curative Treatment for Type II Diabetes?

Start date: November 1, 2013
Phase: N/A
Study type: Interventional

Single- Anastomosis gastric bypass (SAGB) is a potentially curative line of treatment for type II diabetes mellitus (T2DM) patients with BMI 25-30 kg/m2. Accordingly, SAGB could be integrated into T2DM treatment algorithm

NCT ID: NCT02749305 Recruiting - Bariatric Surgery Clinical Trials

Comparative Effectiveness of Bariatric Surgery With PROMs

LOBSTER PROMs
Start date: March 2016
Phase: N/A
Study type: Interventional

This long-term, nationwide observational data collection repository will obtain patient-reported outcomes from metabolic and bariatric surgery patients. The data will be used in conjunction with clinical outcomes to determine quality, safety, and comparative effectiveness of various metabolic and bariatric procedures.

NCT ID: NCT02301416 Completed - Obesity Clinical Trials

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Start date: December 2014
Phase: Phase 2
Study type: Interventional

This study tests the efficacy of the medication, Qsymia, as an adjunct therapy in superobese individuals planning to undergo weight loss surgery. Individuals taking the medication before and after surgery will be compared to historical controls who had surgery without taking the medication.